Structures by: Chicha H.
Total: 17
Ethyl (<i>E</i>)-2-(2,7-dimethyl-5-oxo-4<i>H</i>,5<i>H</i>-pyrano[4,3-<i>b</i>]pyran-4-ylidene)acetate
C14H14O5
IUCrData (2017) 2, 2 x170208
a=9.5679(12)Å b=11.4330(13)Å c=12.7993(15)Å
α=90° β=108.257(4)° γ=90°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-7-yl)benzenesulfonamide hemihydrate
C15H15N3O3S,0.5(H2O)
IUCrData (2017) 2, 5 x170645
a=8.3013(5)Å b=13.1934(8)Å c=15.3583(9)Å
α=103.241(3)° β=105.470(3)° γ=93.046(3)°
<i>N</i>-(2-Allyl-4-ethoxy-2<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2014) 70, 5 o624
a=26.0808(5)Å b=7.9335(2)Å c=21.1573(4)Å
α=90.00° β=122.8390(10)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H20ClN3O3S
Acta Crystallographica Section E (2014) 70, 6 o653
a=10.0345(2)Å b=10.5208(2)Å c=10.7237(2)Å
α=71.5610(10)° β=69.6010(10)° γ=83.0390(10)°
<i>N</i>-(3-Chloro-4-ethoxy-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C17H18ClN3O4S
Acta Crystallographica Section E (2014) 70, 6 o679
a=8.5296(9)Å b=8.6165(9)Å c=12.9821(14)Å
α=91.810(6)° β=102.566(5)° γ=100.514(5)°
<i>N</i>-(3-Chloro-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C14H12ClN3O3S
Acta Crystallographica Section E (2013) 69, 11 o1632
a=16.1229(5)Å b=10.0562(3)Å c=9.7955(2)Å
α=90.00° β=105.3880(10)° γ=90.00°
<i>N</i>-(1<i>H</i>-Indazol-5-yl)-4-methoxybenzenesulfonamide
C14H13N3O3S
Acta Crystallographica Section E (2013) 69, 11 o1702
a=8.9996(4)Å b=7.1999(3)Å c=21.3728(10)Å
α=90.00° β=91.794(3)° γ=90.00°
<i>N</i>-(3-Chloro-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C15H14ClN3O3S
Acta Crystallographica Section E (2014) 70, 9 o983-o984
a=8.20230(10)Å b=10.6312(2)Å c=10.8957(2)Å
α=117.5230(10)° β=93.0950(10)° γ=103.1660(10)°
<i>N</i>-(3-Chloro-1-methyl-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C15H14ClN3O2S
Acta Crystallographica Section E (2014) 70, 2 o181
a=8.4580(13)Å b=34.920(6)Å c=10.8333(17)Å
α=90.00° β=97.226(7)° γ=90.00°
<i>N</i>-(1-Allyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide hemihydrate
2(C17H17N3O3S),H2O
Acta Crystallographica Section E (2013) 69, 10 o1589-o1590
a=8.2099(7)Å b=13.8928(12)Å c=15.0495(14)Å
α=90.00° β=92.327(3)° γ=90.00°
4-Methyl-<i>N</i>-(1-methyl-1<i>H</i>-indazol-5-yl)benzenesulfonamide
C15H15N3O2S
Acta Crystallographica Section E (2013) 69, 9 o1471
a=8.0026(3)Å b=12.8195(4)Å c=14.1321(4)Å
α=90.00° β=91.602(2)° γ=90.00°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-5-yl)benzenesulfonamide
C15H15N3O3S
Acta Crystallographica Section E (2013) 69, 9 o1398
a=10.1069(3)Å b=13.6178(3)Å c=10.8530(2)Å
α=90.00° β=90.777(2)° γ=90.00°
1-Allyl-3-chloro-5-nitro-1<i>H</i>-indazole
C10H8ClN3O2
Acta Crystallographica Section E (2013) 69, 9 o1410
a=13.3025(6)Å b=11.2505(5)Å c=7.3092(3)Å
α=90.00° β=91.343(2)° γ=90.00°
<i>N</i>-(2-Allyl-4-chloro-2<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide hemihydrate
C17H16ClN3O3S,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 8 o1353
a=23.5515(9)Å b=8.9081(3)Å c=20.8278(8)Å
α=90.00° β=122.628(2)° γ=90.00°
<i>N</i>-(1-Allyl-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C17H17N3O2S
Acta Crystallographica Section E (2013) 69, 12 o1847
a=8.8200(4)Å b=10.4769(5)Å c=19.7407(10)Å
α=80.2110(10)° β=78.9840(10)° γ=69.7840(10)°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-\ methoxybenzenesulfonamide
C19H20ClN3O4S
Acta Crystallographica Section E (2014) 70, 9 o1029-o1030
a=8.2699(7)Å b=13.1235(12)Å c=10.0026(9)Å
α=90.00° β=110.379(5)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C17H16ClN3O2S
Acta Crystallographica Section E (2014) 70, 9 o1041-o1042
a=8.1736(12)Å b=22.504(4)Å c=19.279(3)Å
α=90.00° β=90.00° γ=90.00°